03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Caelyx² : | |
Type | Medicine Authorised |
Originator | B |
Agent | Abela Freres |
Distributor | Abela Freres |
Laboratory | Baxter |
Responsible Party | Baxter Holding BV |
Origin | The Netherlands |
Manufacturer | Janssen Pharmaceutica N.V. |
Origin | The Netherlands |
ATC | L01DB01 |
Caelyx² :
Caelyx² :
Caelyx² :
Caelyx² :
Caelyx² :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Caelyx² :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Abdominal pain upper | Common |
Acne | Common |
Acute myeloid leukaemia | Not known |
Allergic reaction | Common |
Alopecia | Very Common |
ALT increased | Common |
Anaemia | Very Common |
Anaphylactoid reactions | Not known |
Anorexia | Very Common |
Anxiety | Common |
Aphthous stomatitis | Common |
Arthralgia (Pain joint) (Joint ache) | Common |
AST increased | Common |
Asthenia | Very Common |
Asthma | Not known |
Back pain | Common |
Bilirubin total increased | Not known |
Blood alkaline phosphatase increased | Not known |
Blood creatinine increased | Common |
Bone marrow failure (Myelosuppression) | Not known |
Bone pain | Common |
Breast pain | Common |
Cachexia | Common |
Candidiasis (Candida infection) | Not known |
Cardiovascular disorders | Common |
Chest pain | Common |
Chest tightness | Not known |
Chills | Common |
Cold sores | Common |
Confusion | Uncommon |
Congestive heart failure | Not known |
Conjunctivitis | Common |
Constipation | Very Common |
Convulsion | Not known |
Cough | Common |
Cough increased | Common |
Cytomegalovirus infection | Not known |
Decreased appetite | Common |
Dehydration | Common |
Depression | Common |
Dermatitis | Common |
Dermatitis allergic | Common |
Dermatitis bullous | Common |
Dermatitis exfoliative | Common |
Diarrhoea (Diarrhea) | Very Common |
Dizziness | Common |
Drug eruption | Common |
Drug interaction | Not known |
Dry mouth (Xerostomia) | Common |
Dry skin | Common |
Dysaesthesia | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Common |
Dyspepsia | Common |
Dysphagia | Common |
Dyspnoea (dyspnea) | Common |
Dyspnoea exertional | Common |
Dysuria (Micturition painful) | Common |
Ejection fraction decreased | Common |
Epistaxis (Nasal bleeding) | Common |
Erythema | Common |
Erythema multiforme | Very rare |
Face oedema | Not known |
Fatigue | Very Common |
Febrile neutropenia (Neutropenic fever) | Common |
Fever | Common |
Flatulence | Common |
Flushing | Common |
Folliculitis | Common |
Fungal infection | Common |
Gastritis | Common |
Gingivitis | Common |
Glossitis | Common |
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) | Very Common |
Headache | Very Common |
Herpes simplex | Common |
Herpes zoster | Common |
Hyperkalaemia | Common |
Hypertension | Common |
Hyperthermia | Common |
Hypertonia | Common |
Hypocalcaemia | Common |
Hypochromic anaemia | Common |
Hypoesthesia | Common |
Hypokalaemia | Common |
Hypomagnesaemia | Common |
Hyponatraemia (Hyponatremia) | Common |
Hypotension | Common |
Infection | Common |
Influenza-like illness | Common |
Infusion related reaction | Common |
Injection site reaction | Not known |
Insomnia | Common |
Lacrimation | Common |
Leg cramps | Common |
Leg oedema | Common |
Lethargy | Common |
Leucopenia (Leukopenia) | Very Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Lymphopenia | Common |
Maculopapular rash | Common |
Malaise | Common |
Mouth ulceration | Common |
Mucositis | Very Common |
Mucous membrane disorder | Very Common |
Muscle spasms | Common |
Muscle weakness | Common |
Musculoskeletal chest pain | Common |
Musculoskeletal pain | Common |
Myalgia | Common |
Mycobacterium avium complex infection | Not known |
Myelodysplasia | Not known |
Nail disorders | Common |
Nasopharyngitis | Common |
Nausea | Very Common |
Neuralgia | Very Common |
Neuropathy | Common |
Neuropathy peripheral | Common |
Neutropenia | Very Common |
Oedema | Common |
Oedema peripheral | Common |
Oesophagitis | Common |
Opportunistic infections | Not known |
Oral moniliasis | Common |
Oral neoplasm | Very rare |
Oral pain | Common |
Orthostatic hypotension | Common |
Pain | Common |
Pain in extremity (Pain in limb) | Common |
Paraesthesia (paresthesia) | Common |
Peripheral sensory neuropathy | Very Common |
Petechiae | Common |
Pharyngitis | Common |
Phlebitis | Common |
Pigmentation abnormal | Common |
Pneumocystis carinii pneumonia | Not known |
Pneumonia | Common |
Polyneuropathy | Common |
Pruritus | Common |
Pulmonary embolism | Uncommon |
Pyrexia | Very Common |
Rash erythematous | Common |
Rash papular | Common |
Retinitis | Common |
Scrotal erythema | Common |
Sepsis (Systemic infection) (Sepsis state) | Not known |
Serum creatinine increased | Not known |
Shortness of breath | Not known |
Skin discolouration (Dyschromia) | Common |
Skin disorders | Common |
Skin hyperpigmentation | Common |
Skin rash | Very Common |
Skin scaly | Common |
Skin ulcer | Common |
Somnolence | Common |
Stevens-Johnson syndrome | Very rare |
Stomatitis | Very Common |
Sweating | Common |
Syncope | Common |
Tachycardia | Not known |
Throat tightness | Not known |
Thrombocytopenia (Thrombopenia) | Very Common |
Thromboembolism venous | Uncommon |
Thrombophlebitis | Uncommon |
Upper respiratory tract infection | Common |
Urinary tract infection | Common |
Urticaria | Not known |
Vaginitis | Common |
Vasodilation | Common |
Venous thrombosis | Uncommon |
Ventricular arrhythmia | Common |
Vesiculobullous rash | Common |
Vision blurred | Common |
Vomiting | Very Common |
Weakness | Common |
Weight decreased (Weight loss) | Common |
Caelyx² :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Caelyx² MoH 11020 :
Form | Concentrate for solution for infusion |
Packaging | Vial (Type I Glass) |
Package Size | 10ml |
Strength | 20mg |
Storage Condition | 2-8°C Do not freeze |
Public Price | 5319412.94 L.L. |
Stratum | D |
NSSF | ✔ |
Quarantine | ✘ |
Reg. Number | 40122/1 |
Submission date | 2022 |
Registration Year | 01/02/2023 |
Price Comparison
● Country: | Czech Republic | |
● Package Size: | 1x10ml | |
● Public Price: | 20055.53 CZK | ( 76,592,069.07 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 20055,53 CZK | ( 76,590,045.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 |
● Country: | Germany | |
● Package Size: | 1x10ml | |
● Public Price: | 693.12 EUR | ( 67,146,693.12 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 693,12 EUR | ( 67,135,068.00 LBP ) |
● Pricing Date: | 20/10/2020 |
● Country: | Switzerland | |
● Package Size: | 1x10ml | |
● Public Price: | 641.6 CHF | ( 66,354,272.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 641,6 CHF | ( 66,292,220.00 LBP ) |
● Pricing Date: | 04/04/2021 |
● Country: | Oman | |
● Package Size: | 1x10ml | |
● Public Price: | 285.82 OMR | ( 65,948,391.88 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 285,82 OMR | ( 65,759,190.00 LBP ) |
● Pricing Date: | 19/02/2021 |
● Country: | Abu Dhabi | |
● Package Size: | 1x10ml | |
● Public Price: | 2536.5 AED | ( 61,284,376.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2536,5 AED | ( 61,272,296.00 LBP ) |
● Pricing Date: | 27/01/2021 |
● Country: | UAE | |
● Package Size: | 10ml Vial | |
● Public Price: | 2536.5 AED | ( 61,284,376.50 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 2536,5 AED | ( 61,272,296.00 LBP ) |
● Pricing Date: | 21/08/2019 |
● Country: | Bahrain | |
● Package Size: | 1x10ml | |
● Public Price: | 241.28 BHD | ( 57,360,459.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 241,28 BHD | ( 57,293,894.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 |
● Country: | Finland | |
● Package Size: | 1x10ml | |
● Public Price: | 555.19 EUR | ( 53,784,586.44 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 555,19 EUR | ( 53,766,180.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 |
● Country: | Italy | |
● Package Size: | 1x10ml | |
● Public Price: | 520.82 EUR | ( 50,454,958.32 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 520,82 EUR | ( 50,375,520.00 LBP ) |
● Pricing Date: | 17/12/2019 |
● Country: | Denmark | |
● Package Size: | 1x10 ml | |
● Public Price: | 3438.05 DKK | ( 44,612,136.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 3438,05 DKK | ( 44,611,488.00 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 |
● Country: | Iceland | |
● Package Size: | 1x10ml | |
● Public Price: | 68030 ISK | ( 43,879,350.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 68030 ISK | ( 43,879,350.00 LBP ) |
● Reference: | Icelandic Medicines Agency | |
● Pricing Date: | 01/04/2020 |
● Country: | The Netherlands | |
● Package Size: | 1x10ml | |
● Public Price: | 448.37 EUR | ( 43,436,292.12 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 448,37 EUR | ( 43,400,448.00 LBP ) |
● Reference: | Zorginstituut Nederland | |
● Pricing Date: | 15/06/2019 |
● Country: | Cyprus | |
● Package Size: | 10ml | |
● Public Price: | 445.5 EUR | ( 43,158,258.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 445,5 EUR | ( 43,109,820.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 |
● Country: | Jordan | |
● Package Size: | 1x10ml | |
● Public Price: | 331.12 JOD | ( 41,463,177.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 331,12 JOD | ( 41,448,151.00 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 |
● Country: | UK | |
● Package Size: | 1x10ml | |
● Public Price: | 360.23 GBP | ( 40,939,779.27 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 360,23 GBP | ( 40,913,640.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 |
● Country: | Spain | |
● Package Size: | 1x10ml | |
● Public Price: | 399.48 EUR | ( 38,700,024.48 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 399,48 EUR | ( 38,653,524.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 |
● Country: | Norway | |
● Package Size: | 1x10ml | |
● Public Price: | 4405 NOK | ( 35,698,120.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 4405 NOK | ( 35,698,120.00 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 |
● Country: | Greece | |
● Package Size: | 1x10ml | |
● Public Price: | 362.37 EUR | ( 35,104,956.12 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 362,37 EUR | ( 35,069,112.00 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 |
● Country: | Belgium | |
● Package Size: | 1x10ml | |
● Public Price: | 320 EUR | ( 31,000,320.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 320 EUR | ( 31,000,320.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 |
● Country: | Lebanon | |
● Form: | Concentrate for solution for infusion | |
● Package Size: | 10ml | |
● Public Price: | 5319412.94 LBP | ( 5,319,412.94 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 5319412,94 LBP | ( 5,319,412.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Turkey | |
● Package Size: | 1x10ml | |
● Public Price: | 1660.86 TRY | ( 4,451,104.80 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1660,86 TRY | ( 4,448,800.00 LBP ) |
● Pricing Date: | 31/12/2019 |
● Country: | Egypt | |
● Package Size: | 10ml | |
● Public Price: | 1820 EGP | ( 3,321,500.00 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 1820 EGP | ( 3,321,500.00 LBP ) |
● Pricing Date: | 02/12/2019 |
● Country: | Portugal |
● Package Size: | 1x10ml |
● Reference: | Autoridade Nacional do Medicamento e Produtos de Saúde |
● Pricing Date: | 22/04/2019 |
● Country: | Qatar |
● Package Size: | 1x10ml |
● Pricing Date: | 13/01/2020 |
● Country: | France |
● Package Size: | 1x10ml |
● Reference: | ansm |
● Pricing Date: | 15/05/2021 |
Note
You have to register to view this info
Drop File